Corrigendum on: **Figure [6](#F6){ref-type="fig"} \| Primary breast cancer (Brc) cells basal levels of secretion of inflammatory cytokines**.

![Primary breast cancer (BrC) cells basal levels of secretion of inflammatory cytokines. **(A)** The levels of the cytokines, chemokines, and growth factors of interest were determined in the supernatants of the 3D cultures of BrC primary isolates. Each point represents the mean of three determinations made for three independent cultures. The horizontal line represents the average of the primary cultures readings. **(B)** Comparison of the migratory properties of monocytes in response to GM-CSF, MCP-1, and RANTES. **(C)** Invasion assay with the commercial BrC cell lines in response to IL-8. Three independent experiments were performed. Statistical significance is indicated by \*\*\**p* \< 0.001 and \*\**p* \< 0.01.](fimmu-08-00856-g006){#F6}

In the original article, there was a mistake in the Figure [6](#F6){ref-type="fig"}, **panel B** as published. **The scale in the Y axes is incorrect**. The corrected appears below: should be 20, 15, 10 and 5, instead of 200, 150, 100 and 50. The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way.
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